CLINICAL_TRIALS
trial_result
· 2019-03-08
Clinical Trial Update: Japan Phase 2/3 Clinical Study With BLM-240 (Desflurane) [Phase 2, Phase 3]
Summary
A Phase 2/3 clinical study of BLM-240 (desflurane) in Japan has completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baxter Healthcare Corporation | Conditions: Anesthesia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-03-08